Lifeboat Foundation

IBM’s Summit is currently the fastest supercomputer in the world.

Shares in Fujifilm Toyama Chemical, which developed favipiravir, surged after praise by Chinese official following clinical trials.

Marsha Blackburn (R-TN); Jim Inhofe (R-OK); James Lankford (R-OK); Mike Lee (R-UT); Rand Paul (R-KY); Ben Sasse (R-NE); Tim Scott (R-SC), and Ron Johnson (R-WI).

Also presented without comment: Sasse and Inhofe will run for re-election this fall.

Vitamin D may be effective in helping to prevent Covid-19:

PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from Central and publisher web sites.

This Is-Real!!! Israeli pharmaceutical company, Teva, has announced that they will donate more than 6 million tablets through wholesalers to hospitals across the United States, from March 31.

As the coronavirus is spreading across the world, and the number of people infected is increasing everyday, there is an urgent need to find treatments against COVID-19 that could reduce complications and improve recovery. Recently, the Israeli Health Ministry has approved multiple experiment treatments, and companies worldwide are attempting to determine what could be used to treat COVID-19.

As such, Israeli pharmaceutical company, Teva, has announced that they will donate more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the United States, from March 31. Over 10 million tablets are expected to be shipped within a month.

Continue reading “Teva donates potential coronavirus treatment to hospitals across the US” »

Hydroxychloroquine one of several drugs cited in recent days as being possibly effective against coronavirus; Israeli firm says it will provide as many as possible at no cost.

The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month.

Israeli generic drug giant Teva announced Friday that it will provide ten million doses of its anti-malarial drug hydroxychloroquine, which could potentially prove effective in fighting the coronavirus pandemic, to US hospitals free of charge. The company said six million doses will be delivered to US hospitals by March 31, and more than ten million in a month. “We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” Teva executive vice president Brendan O’Grady said. Get The Times of Israel’s Daily Edition by email and never miss our top stories Free Sign Up.

Continue reading “Teva to send US millions of malaria pills with potential to help COVID-19” »

2020, Antiviral Research

In the face of overwhelming demand and limited resources, health care would need to be rationed, with agonizing decisions.

As the coronavirus spreads through Colorado, local distilleries like Spirit Hound have begun making hand sanitizer.